HAEMOcare: The First International Epidemiological Study Measuring Burden of Hemophilia in Developing Countries

TH Open

Yasser Wali¹  Meriem Belhani²  Naresh Gupta³  Abderrahmane Benbouzid⁴  Khadija Maani⁵  Johnny Mahlangu⁶  Soraya Benchikh El Fegoun⁷  Hossam Ali Saad⁸  Mohammed El Andaloussi⁹ 

[1] Department of Child Health, Sultan Qaboos University, Muscat, Oman;Department of Haematology, University Hospital of Beni Messous, Beni Messous, Algeria;Department of Medicine and The Haemophilia Centre, Maulana Azad Medical College & Associated Lok Nayak and GB Pant Hospitals, New Delhi, India;Department of Orthopaedics, University Medical Centre of Ben Aknoun, Ben Aknoun, Algeria;Department of Paediatrics, Haematology and Oncology Unit, Abderrahim Harouchi University Children's Hospital–Medical School of Casablanca, Casablanca, Morocco;Haemophilia Comprehensive Care Centre, Charlotte Maxeke Johannesburg Hospital, Department of Molecular Medicine and Haematology, National Health Laboratory Service and Faculty of the Health Sciences, University of Witwatersrand, Johannesburg, South Africa;Novo Nordisk Health Care AG, Zurich, Switzerland;Novo Nordisk Inc., Plainsboro, New Jersey, United States;Paediatric Orthopaedic and Traumatology Service, Abderrahim Harouchi Hospital, Part of the Ibn Rochd University Hospital, Casablanca, Morocco;

关键词: haemocare;    epidemiological study;    hemophilia;    inhibitors;    orthopedic status;    quality of life;    developing countries;   

DOI  :  10.1055/s-0039-1688414

来源: DOAJ

【 授权许可】

Unknown